Previtali, V, Keiding, U B, Olsen, A H, Peiró Cadahía, J, Clausen, A S, Kjaer, A, Andresen, T L, Hansen, A E & Clausen, M H 2022, ' Synthesis and evaluation of hydrogen peroxide sensitive tofacitinib prodrugs ', European Journal of Medicinal Chemistry Reports, vol. 4, 100019 . https://doi.org/10.1016/j.ejmcr.2021.100019
Previtali, V, Petrovic, K, Peiro Cadahía, J, Troelsen, N S & Clausen, M H 2020, ' Auxiliary in vitro and in vivo biological evaluation of hydrogen peroxide sensitive prodrugs of methotrexate and aminopterin for the treatment of rheumatoid arthritis ', Bioorganic & Medicinal Chemistry, vol. 28, no. 2, 115247 . https://doi.org/10.1016/j.bmc.2019.115247
Peiró Cadahía, J, Bondebjerg, J, Hansen, C A, Previtali, V, Hansen, A E, Andresen, T L & Clausen, M H 2018, ' Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis ', Journal of Medicinal Chemistry, vol. 61, no. 8, pp. 3503-3515 . https://doi.org/10.1021/acs.jmedchem.7b01775
Peiro Cadahia, J, Previtali, V, Troelsen, N S & Clausen, M H 2019, ' Prodrug strategies for targeted therapy triggered by reactive oxygen species ', MedChemComm, vol. 10, no. 9, pp. 1531-1549 . https://doi.org/10.1039/C9MD00169G Medchemcomm
Andersen, N S, Peiro Cadahia, J, Previtali, V, Bondebjerg, J, Hansen, C A, Hansen, A E, Andresen, T L & Clausen, M H 2018, ' Methotrexate Prodrugs Sensitive to Reactive Oxygen Species for the Improved Treatment of Rheumatoid Arthritis ', European Journal of Medicinal Chemistry, vol. 156, pp. 738-746 . https://doi.org/10.1016/j.ejmech.2018.07.045
Peiro Cadahia, J, Clausen, M H, Bondebjerg, J & Hansen, C A, Prodrugs activated by reactive oxygen species for use in the treatment of inflammatory diseases and cancer, Patent No. WO2017EP71457 . Technical University of Denmark Orbit CIÊNCIAVITAE
Technical University of Denmark Orbit CIÊNCIAVITAE Peiro Cadahia, J, Clausen, M H, Bondebjerg, J, Hansen, C A & Andersen, N S, Thiazolidinone prodrugs activated by reactive oxygen species for use in the treatment of inflammatory diseases and cancer, Patent No. WO2018037119 .